Spiros Kotopoulis 6/1/23 Spiros Kotopoulis 6/1/23

DoMore Diagnostics welcomes Andreas Berg Storsve as our new VP Operations

DoMore Diagnostics is pleased to announce the appointment of Andreas Berg Storsve, PhD as VP Operations. Dr. Storsve will join the management team and take a leading role in driving partnerships and business development activities forward.

Spiros Kotopoulis 1/23/23 Spiros Kotopoulis 1/23/23

DoMore Diagnostics has successfully completed ISO 13485 certification

DoMore Diagnostics today announced that the quality management system (QMS) has been certified as compliant with the ISO 13485 standard. The certification audit process was conducted by DNV (notified body).

Spiros Kotopoulis 1/18/23 Spiros Kotopoulis 1/18/23

DoMore Diagnostics announces expansion of the Scientific Advisory Board

DoMore Diagnostics announces Dr. Takayuki Yoshino, MD, Professor Hans-Joachim Schmoll, MD, Dr. Jakob Nikolas Kather, MD, and Dr. Marc Peeters, MD are joining the Scientific Advisory Board. The four leaders in GI oncology will undoubtedly make vital contributions in bringing the company forward.

Spiros Kotopoulis 12/7/22 Spiros Kotopoulis 12/7/22

DoMore Diagnostics announces successful integration with the Sectra software platform for digital pathology

DoMore Diagnostics today announced that its Histotype Px Colorectal outcome prediction marker is available on the Sectra pathology imaging platform, facilitating seamless and easy access to this cutting-edge technology.

Spiros Kotopoulis 8/12/22 Spiros Kotopoulis 8/12/22

Impressive results with The Histotype Px Colorectal cancer marker published in The Lancet Oncology

DoMore Diagnostics today announced that The Lancet Oncology has published an article documenting that the Histotype Px Colorectal algorithm even more accurately predicts patient outcomes when used in combination with tumor and lymph node status.

Spiros Kotopoulis 5/25/22 Spiros Kotopoulis 5/25/22

DoMore Diagnostics achieves CE-IVD mark for Histotype Px® Colorectal, an AI algorithm that predict patient outcomes in colorectal cancer patients by analyzing standard histology images

Spiros Kotopoulis 5/9/22 Spiros Kotopoulis 5/9/22

DoMore Diagnostics congratulates Prof. Håvard Danielsen with the King Olav V´s Cancer Research Prize for 2022

DoMore Diagnostics congratulates Prof. Håvard Danielsen with the King Olav V´s Cancer Research Prize for 2022. The prestigious prize was handed over by HM Kong Harald V on behalf of the Norwegian Cancer Society in Oslo on May 9.